Professor
Director, Division of Behavioral Biology
Main Office Address
Behavioral Biology Research Center, Room 3000
Johns Hopkins Bayview Campus
5510 Nathan Shock Drive
Baltimore, MD 21224
Phone 410-550-2773
Fax 410-550-2780
E-mail: ator@jhmi.edu
Administrative Assistant
Kelley Waddell
Phone: 410-550-2800
Email: kwaddel2@jhmi.edu
Education
1972 | B.A. | University of Maryland, College Park |
1974 | M.S. | University of Maryland, College Park |
1978 | Ph.D. | University of Maryland, College Park |
1978-1982 | Postdoctoral Fellowship | The Johns Hopkins Universtity School of Medicine |
Professional Interests
- Behavioral pharmacology and drug abuse
- Preclinical characterization of anxiolytics, hypnotics
- In vivo characterization of selective GABAergic compounds to determine behavioral relevance of novel in-vitro activity with respect to drug abuse
- Study of interoceptive stimulus functions of psychoactive drugs
Selected Publications
Ator NA, Weerts EM, Kaminski, BJ, Kautz MA, Griffiths RR. Zaleplon and triazolam physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons. Drug and Alcohol Dependence:61:69-84. (2000)
Ator NA, Kautz MA. Differentiating benzodiazepine and barbituate-like discriminative stimulus effects of lorazepam, diazepam, pentobarbital, imidazenil, and zaleplon in two versus three lever procedures. Behavioural Pharmacology:11:1-14. (2000)
Ator NA. Zaleplon and triazolam: Drug discrimination, plasma levels, and self-administration in baboons. Drug and Alcohol Dependence: 61:69-84. (2000)
Ator NA. Relation between discriminative and reinforcing effects of midazolam, pentobarbital, chlordiazepoxide, zolpidem, and imidazenil in baboons. Psychopharmacology: 163:477-487. (2002)
Ator NA, Griffiths RR. Principles of drug abuse liability assessment in laboratory animals. Drug and Alcohol Dependence: 70: S55-S72. (2003)
Ator NA. Contributions of GABAa receptor subtype selectivity to abuse liability and dependence potential of pharmacological treatments for anxiety and sleep disorders. CNS Spectrums:10: 31-39. (2005)
